Protein nanopharmaceuticals - concepts and safety considerations
Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Standard
Protein nanopharmaceuticals - concepts and safety considerations. / Møller, Eva Horn; Jørgensen, Lene; Medlicott, Natalie J.
Nanopharmaceutics: the potential application of nanomaterials. ed. / Xing-Jie Liang. Singapore : World Scientific, 2013. p. 49-.Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Research › peer-review
Harvard
Møller, EH, Jørgensen, L & Medlicott, NJ 2013, Protein nanopharmaceuticals - concepts and safety considerations. in X-J Liang (ed.), Nanopharmaceutics: the potential application of nanomaterials. World Scientific, Singapore, pp. 49-.
APA
Møller, E. H., Jørgensen, L., & Medlicott, N. J. (2013). Protein nanopharmaceuticals - concepts and safety considerations. In X-J. Liang (Ed.), Nanopharmaceutics: the potential application of nanomaterials (pp. 49-). World Scientific.
Vancouver
Møller EH, Jørgensen L, Medlicott NJ. Protein nanopharmaceuticals - concepts and safety considerations. In Liang X-J, editor, Nanopharmaceutics: the potential application of nanomaterials. Singapore: World Scientific. 2013. p. 49-
Author
Bibtex
@inbook{d9b54ddd7ad341188c5ef3428961f29c,
title = "Protein nanopharmaceuticals - concepts and safety considerations",
author = "M{\o}ller, {Eva Horn} and Lene J{\o}rgensen and Medlicott, {Natalie J.}",
year = "2013",
language = "English",
isbn = "978-981-4368-66-7",
pages = "49--",
editor = "Xing-Jie Liang",
booktitle = "Nanopharmaceutics",
publisher = "World Scientific",
address = "United States",
}
RIS
TY - CHAP
T1 - Protein nanopharmaceuticals - concepts and safety considerations
AU - Møller, Eva Horn
AU - Jørgensen, Lene
AU - Medlicott, Natalie J.
PY - 2013
Y1 - 2013
M3 - Book chapter
SN - 978-981-4368-66-7
SP - 49-
BT - Nanopharmaceutics
A2 - Liang, Xing-Jie
PB - World Scientific
CY - Singapore
ER -
ID: 44836647